Key result
Non-elite athletes suffer more acute respiratory infections than elites, with ~5 overall cases per 1000 days.
Why the study?
To determine the incidence of acute respiratory illness in athletes and evaluate variations across diagnostic methods, anatomical classifications, ages, performance levels, and seasons.
Meta-Analysis (n=128,360)
Acute respiratory illness occurs at a rate of approximately 4.7 per 1000 athlete days, with non-elite athletes experiencing significantly higher rates of infection than elite athletes.
Answers are grounded in this paper and cite their sources.
Informs ARill surveillance and prevention priorities in sports medicine; extends prior estimates by quantifying incidence across athlete levels.
OBJECTIVE: To determine the incidence of acute respiratory illness (ARill) in athletes and by method of diagnosis, anatomical classification, ages, levels of performance and seasons. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Electronic databases: PubMed-Medline, EbscoHost and Web of Science. ELIGIBILITY CRITERIA: Original research articles published between January 1990 and July 2020 in English reporting the incidence of ARill in athletes, at any level of performance (elite/non-elite), aged 15-65 years. RESULTS: Across all 124 studies (n=1 28 360 athletes), the incidence of ARill, estimated by dividing the number of cases by the total number of athlete days, was 4.7 (95% CI 3.9 to 5.7) per 1000 athlete days. In studies reporting acute respiratory infections (ARinf; suspected and confirmed) the incidence was 4.9 (95% CI 4.0 to 6.0), which was similar in studies reporting undiagnosed ARill (3.7; 95% CI 2.1 to 6.7). Incidences of 5.9 (95% CI 4.8 to 7.2) and 2.8 (95% CI 1.8 to 4.5) were found for studies reporting upper ARinf and general ARinf (upper or lower), respectively. The incidence of ARinf was similar across the different methods to diagnose ARinf. A higher incidence of ARinf was found in non-elite (8.7; 95% CI 6.1 to 12.5) vs elite athletes (4.2; 95% CI 3.3 to 5.3). SUMMARY/CONCLUSIONS: These findings suggest: (1) the incidence of ARill equates to approximately 4.7 per athlete per year; (2) the incidence of upper ARinf was significantly higher than general (upper/lower) ARinf; (3) elite athletes have a lower incidence of ARinf than non-elite athletes; (4) if pathogen identification is not available, physicians can confidently use validated questionnaires and checklists to screen athletes for suspected ARinf. For future studies, we recommend that a clear diagnosis of ARill is reported. PROSPERO REGISTRATION NUMBER: CRD42020160472.
No takes yet. Share an insight, caveat, or question.
Derman et al. (2022) conducted a meta-analysis in Acute respiratory illness (n=128,360). The overall incidence of acute respiratory illness in athletes was 4.7 per 1000 athlete days, with non-elite athletes experiencing a higher incidence of infections than elite athletes.
Synapse has enriched 10 related papers. Consider them for comparative context: